Table 1 Vaccine egg-adapted mutations in the HA head domain of egg-grown vaccine viruses and CVVs in year 1 and year 2 of the study

From: Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines

Viruses

Amino acids differences on the HA head domain

A(H1N1)pdm09

45

74

120

164

183

209

223

225

282

295

298

     

Year 1

A/Michigan/45/2015 cell a

R

S

T

S

S

K

Q

G

P

I

I

     

A/Michigan/45/2015 egg

R

S

T

S

S

K

R

G

P

I

I

     

A/Michigan/45/2015 X-275 egg CVV (EPI830246) b

R

S

T

S

S

M

R

G

P

I

I

     

A/Singapore/GP1908/2015 IVR-180 egg CVV (EPI848715) c,d

R

S

A

S

S

K

Q

A

P

I

I

     

Year 2

A/Idaho/07/2018 cell a,d

R

R

T

T

P

K

Q

G

P

V

I

     

A/Brisbane/02/2018 egg b

G

R

T

T

P

K

R

G

A

V

V

     

A(H3N2)

91

121

128

138

142

144

158

159

160

171

190

193

194

225

246

311

Year 1

A/Singapore/INFIMH-16-0019/2016 cell a

S

K

T

A

G

S

N(CHO)

Y

T

K

D

F

L

D

N

H

A/Singapore/INFIMH-16-0019/2016 egg

S

K

T

A

G

S

N(CHO-)

Y

K

K

D

F

P

D/G

N

H

A/Singapore/INFIMH-16-0019/2016 IVR-186 egg CVV (EPI1082512) b

S

K

T

A

G

S

N(CHO-)

Y

K

K

D

F

P

G

N

H

A/Singapore/INFIMH-16-0019/2016 NIB-104 egg CVV (EPI1151864) c

S

K

T

A

G

S

N(CHO-)

Y

K

K

D

F

P

G

N

H

A/North Carolina/04/2016 cell (EPI701956) d

S

N

T

A

R

S

N(CHO)

Y

T

K

D

F

L

D

N

H

Year 2

A/Kansas/14/2017 cell a,d

N

N

A

S

G

K

N(CHO-)

S

K

N

D

S

L

D

N

Q

A/Kansas/14/2017 egg b

N

N

A

S

G

K

N(CHO-)

S

K

N

N

S

L

D

T

Q

B/Victoria lineage

129

197

199

             

Year 1 & 2

B/Colorado/06/2017 cell

G

N

T

             

B/Colorado/06/2017 egg

G

T(CHO-)

T

             

B/Maryland/15/2016 BX-69A egg CVV (EPI1061863) b,c

D

N(CHO-)

I

             

B/Maryland/15/2016 cell (CY220998) a

D

N

T

             

B/Iowa/06/2017 cell (EPI1619422) d

G

N

T

             

B/Yamagada lineage

154

173

197

252

            

Year 1 & 2

B/Phuket/3073/2013 cell a

A

L

N

M

            

B/Phuket/3073/2013 egg b,c

A

L

D(CHO-)

M

            

B/Singapore/INFTT-16-0610/2016 cell (EPI1843276) d

S

Q

N

V

            
  1. aHA proteins of these vaccine viruses were included in the RIV4 vaccine.
  2. bCVV: candidate vaccine virus used in the Fluzone IIV4.
  3. cCVV used in the Fluarix IIV4 vaccine.
  4. dCVV used in the ccIIV4 vaccine. For A(H1N1)pdm09 virus, the egg CVV was passaged in qualified MDCK cells for manufacturing ccIIV4 used in Year 1.
  5. Mix of D and G.
  6. CHO: Glycosylation motif. CHO-: Loss of glycosylation motif.
  7. Cell grown vaccine viruses used as reference are bolded. HA substitution due to egg-adaptions are italic and bold.
  8. Accession numbers were noted to those reference sequences downloaded from GISAID database.